Galbraith M L, Vorachek W R, Estill C T, Whanger P D, Bobe G, Davis T Z, Hall J A
Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Dryden Hall 206, Corvallis, OR, 97331-4802, USA.
Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR, 97331, USA.
Biol Trace Elem Res. 2016 Jun;171(2):338-343. doi: 10.1007/s12011-015-0560-8. Epub 2015 Nov 5.
Despite the availability of selenium (Se)-enriched trace mineral supplements, we have observed low Se status in cattle and sheep offered traditional inorganic Se supplements. Reasons for this may include inadequate intake or low bioavailability of inorganic Se sources. The objective of this study was to determine whether rumen microorganisms (RMO) alter the bioavailability of Se sources commonly used in Se supplements. Rumen microorganisms were isolated from ewes (n = 4) and incubated ex vivo with no Se (control), with inorganic Na selenite or Na selenate, or with organic selenomethionine (SeMet). Total Se incorporated into RMO and the amount of elemental Se formed were determined under equivalent conditions. Incorporation of Se from Na selenite, Na selenate, or SeMet into RMO was measured as fold change compared with control (no added Se). Incorporation of Se into microbial mass was greater for SeMet (13.2-fold greater than no-Se control) compared with inorganic Se supplements (P = 0.02); no differences were observed between inorganic Na selenate (3.3-fold greater than no-Se control) and Na selenite (3.5-fold greater than no-Se control; P = 0.97). Formation of non-bioavailable, elemental Se was less for RMO incubated with SeMet compared with inorganic Se sources (P = 0.01); no differences were observed between Na selenate and Na selenite (P = 0.09). The clinical importance of these results is that the oral bioavailability of organic SeMet should be greater compared with inorganic Se sources because of greater RMO incorporation of Se and decreased formation of elemental Se by RMO.
尽管有富含硒(Se)的微量矿物质补充剂,但我们观察到,食用传统无机硒补充剂的牛羊硒水平较低。其原因可能包括无机硒源摄入不足或生物利用率低。本研究的目的是确定瘤胃微生物(RMO)是否会改变硒补充剂中常用硒源 的生物利用率。从母羊(n = 4)中分离出瘤胃微生物,并在体外与无硒(对照)、无机亚硒酸钠或硒酸钠,或与有机硒代蛋氨酸(SeMet)一起培养。在相同条件下测定掺入RMO中的总硒量和形成的元素硒量。将亚硒酸钠、硒酸钠或SeMet中的硒掺入RMO的量,与对照(未添加硒)相比,以倍数变化来衡量。与无机硒补充剂相比,SeMet掺入微生物团的硒更多(比无硒对照高13.2倍)(P = 0.02);无机硒酸钠(比无硒对照高3.3倍)和亚硒酸钠(比无硒对照高3.5倍;P = 0.97)之间未观察到差异。与无机硒源相比,用SeMet培养的RMO形成的非生物可利用元素硒较少(P = 0.01);硒酸钠和亚硒酸钠之间未观察到差异(P = 0.09)。这些结果临床意义在于,由于RMO对硒的掺入量更高,且RMO形成的元素硒减少,因此有机SeMet的口服生物利用率应高于无机硒源。